<?xml version="1.0" encoding="UTF-8" standalone="no"?><document setID="5ad82e30-50d8-450c-8a2a-b4b507ed1ce2"><labelDrug name="Integrilin"><Normalization><mmtx cui="C0950902" preferredWord="Integrilin" semType="phsu, aapp"/></Normalization></labelDrug><generic name="Eptifibatide"/><sentence id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.1" text="Drug Label for drug brand Integrilin, containing Eptifibatide." type="negative"><entity charOffset="49:61" id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.1.e.0" text="eptifibatide" type="Biomedical_Entity"><Normalization><mmtx cui="C0253563" phraseText="Eptifibatide." preferredWord="eptifibatide" semType="phsu, aapp"/><RxNorm RxCui="75635"/></Normalization></entity><entity charOffset="0:19" id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.1.e.1" text="drug drug" type="Biomedical_Entity"><Normalization><mmtx cui="C0013231" phraseText="Drug Label for drug brand Integrilin," preferredWord="Drugs, Non-Prescription" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="26:36" id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.1.e.2" text="integrilin" type="Biomedical_Entity"><Normalization><mmtx cui="C0950902" phraseText="Drug Label for drug brand Integrilin," preferredWord="Integrilin" semType="phsu, aapp"/><RxNorm RxCui="288688"/></Normalization></entity><pair ddi="false" e1="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.1.e.1" e2="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.1.e.0"/><pair ddi="false" e1="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.1.e.2" e2="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.1.e.0"/><pair ddi="false" e1="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.1.e.1" e2="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.1.e.2"/></sentence><sentence biomedicalEntities="1" id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.3" lineNumber="7" text="&lt;main&gt;Treatment with INTEGRILIN is contraindicated in patients with:" type="regular"><entity charOffset="35:50" id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.3.e.1" text="contraindicated" type="Caution_Interaction"/><entity charOffset="35:50" id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.3.e.2" text="contraindicated" type="SPAN"/><entity charOffset="21:31" id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.3.e.3" text="INTEGRILIN" type="Drug"><Normalization><mmtx cui="C0950902" phraseText="&gt;Treatment with INTEGRILIN" preferredWord="Integrilin" semType="phsu, aapp"/><RxNorm RxCui="288688"/></Normalization></entity><drugInteraction id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.3.ddi.1"><interaction trigger="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.3.e.1"><relations><relation type="hasSeverity"><entity id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.3.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.15.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.3.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.8.e.0"/></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="1" id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.22" lineNumber="48" text="If heparin is given concomitantly, monitor aPTT or ACT. " type="irregular"><entity charOffset="35:42" id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.22.e.1" text="monitor" type="Caution_Interaction"/><entity charOffset="3:10" id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.22.e.2" text="heparin" type="Drug"><Normalization><mmtx cui="C0019134" phraseText="heparin" preferredWord="Heparin" semType="bacs, phsu, carb"/><mmtx cui="C0770546" phraseText="heparin" preferredWord="heparin, porcine" semType="bacs, phsu, carb"/><RxNorm RxCui="5224"/></Normalization></entity><drugInteraction id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.22.ddi.1"><interaction trigger="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.22.e.1"><relations><relation type="hasObject"><ellipsisSentence id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.20" text="If bleeding cannot be controlled, discontinue INTEGRILIN immediately. "><entity charOffset="46:56" id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.20.e.0" text="INTEGRILIN" type="Drug"><Normalization><mmtx cui="C0950902" phraseText="INTEGRILIN immediately." preferredWord="Integrilin" semType="phsu, aapp"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.21" text="Minimize vascular and other traumas. "/></relation><relation type="hasPrecipitant"><entity id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.22.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.22.e.2"/></sentence><sentence biomedicalEntities="2" id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.24" lineNumber="50" text="&lt;item&gt;Thrombocytopenia: Discontinue INTEGRILIN and heparin. " type="regular"><entity charOffset="6:22" id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.24.e.1" text="Thrombocytopenia" type="Specific_Interaction"/><entity charOffset="51:58" id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.24.e.2" text="heparin" type="Drug"><Normalization><mmtx cui="C0019134" phraseText="heparin." preferredWord="Heparin" semType="bacs, phsu, carb"/><mmtx cui="C0770546" phraseText="heparin." preferredWord="heparin, porcine" semType="bacs, phsu, carb"/><RxNorm RxCui="5224"/></Normalization></entity><entity charOffset="36:46" id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.24.e.3" text="INTEGRILIN" type="Drug"><Normalization><mmtx cui="C0950902" phraseText="INTEGRILIN" preferredWord="Integrilin" semType="phsu, aapp"/><RxNorm RxCui="288688"/></Normalization></entity><entity charOffset="24:35" id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.24.e.5" text="Discontinue" type="Caution_Interaction"/><drugInteraction id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.24.ddi.1"><interaction trigger="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.24.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.24.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.24.e.3"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.24.ddi.2"><interaction trigger="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.24.e.5"><relations><relation type="hasPrecipitant"><entity id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.24.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.24.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.24.e.3" e2="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.24.e.2" trigger="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.24.e.1" type="Specific_Interaction"/></sentence><sentence id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.29" text="Administration of INTEGRILIN is associated with an increase in major and minor bleeding, as classified by the criteria of the Thrombolysis in Myocardial Infarction Study group (TIMI) see Adverse Reactions (6.1). " type="negative"><entity charOffset="18:28" id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.29.e.0" text="integrilin" type="Biomedical_Entity"><Normalization><mmtx cui="C0950902" phraseText="Administration of INTEGRILIN" preferredWord="Integrilin" semType="phsu, aapp"/><RxNorm RxCui="288688"/></Normalization></entity><entity charOffset="126:138" id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.29.e.1" text="thrombolysis" type="Biomedical_Entity"><Normalization><mmtx cui="C0016018" phraseText="classified by the criteria of the Thrombolysis in Myocardial Infarction Study group (TIMI)" preferredWord="Fibrinolytic Agents" semType="phsu"/><RxNorm RxCui="986448"/></Normalization></entity><pair ddi="false" e1="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.29.e.0" e2="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.29.e.1"/></sentence><sentence id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.33" text="Use of Thrombolytics, Anticoagulants, and Other Antiplatelet Agents" type="negative"><entity charOffset="7:20" id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.33.e.0" text="thrombolytics" type="Biomedical_Entity"><Normalization><mmtx cui="C0016018" phraseText="Use of Thrombolytics," preferredWord="Fibrinolytic Agents" semType="phsu"/><RxNorm RxCui="4390"/></Normalization></entity><entity charOffset="48:67" id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.33.e.1" text="antiplatelet agents" type="Biomedical_Entity"><Normalization><mmtx cui="C0085826" phraseText="Other Antiplatelet Agents" preferredWord="Antiplatelet Agents" semType="phsu"/><RxNorm RxCui="42539"/></Normalization></entity><entity charOffset="22:36" id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.33.e.2" text="anticoagulants" type="Biomedical_Entity"><Normalization><mmtx cui="C0003280" phraseText="Anticoagulants," preferredWord="Anticoagulants" semType="phsu"/><RxNorm RxCui="923"/></Normalization></entity><pair ddi="false" e1="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.33.e.0" e2="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.33.e.1"/><pair ddi="false" e1="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.33.e.0" e2="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.33.e.2"/><pair ddi="false" e1="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.33.e.2" e2="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.33.e.1"/></sentence><sentence biomedicalEntities="5" id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.34" lineNumber="59" text="Risk factors for bleeding include older age, a history of bleeding disorders, and concomitant use of drugs that increase the risk of bleeding (thrombolytics, oral anticoagulants, nonsteroidal anti-inflammatory drugs, and P2Y12 inhibitors). " type="irregular"><entity charOffset="101:141" id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.34.e.1" text="drugs that increase the risk of bleeding" type="Drug_Class"><Normalization><mmtx cui="C0013227" phraseText="concomitant use of drugs" preferredWord="Pharmaceutical Preparations" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="143:156" id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.34.e.2" text="thrombolytics" type="Drug_Class"><Normalization><mmtx cui="C0016018" phraseText="(thrombolytics," preferredWord="Fibrinolytic Agents" semType="phsu"/><RxNorm RxCui="4390"/></Normalization></entity><entity charOffset="158:177" id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.34.e.4" text="oral anticoagulants" type="Drug_Class"><Normalization><mmtx cui="C0354604" phraseText="oral anticoagulants," preferredWord="Anticoagulants, Oral" semType="phsu, orch"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="179:215" id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.34.e.6" text="nonsteroidal anti-inflammatory drugs" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="nonsteroidal anti-inflammatory drugs," preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="402125"/></Normalization></entity><entity charOffset="221:237" id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.34.e.8" text="P2Y12 inhibitors" type="Drug_Class"><Normalization><RxNorm RxCui="1027718"/></Normalization></entity><entity charOffset="17:25" id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.34.e.10" text="bleeding" type="Specific_Interaction"/><classClassMembership drugClass="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.34.e.2"/><classClassMembership drugClass="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.34.e.4"/><classClassMembership drugClass="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.34.e.6"/><classClassMembership drugClass="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.34.e.8"/><drugInteraction id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.34.ddi.1"><interaction trigger="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.34.e.10"><relations><relation type="hasPrecipitant"><entity id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.34.e.1"/></relation><relation type="hasObject"><labelDrug text="Integrilin"/><normalization><mmtx><preferredWord>Integrilin</preferredWord><phraseText>&gt;Treatment with INTEGRILIN</phraseText><cuiCode>C0950902</cuiCode><semType>phsu</semType><semType>aapp</semType></mmtx></normalization></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.34.e.1"/></sentence><sentence biomedicalEntities="1" id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.35" lineNumber="59" text="Concomitant treatment with other inhibitors of platelet receptor glycoprotein (GP) IIb/IIIa should be avoided. " type="irregular"><entity charOffset="102:109" id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.35.e.1" text="avoided" type="Caution_Interaction"/><entity charOffset="33:91" id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.35.e.2" text="inhibitors of platelet receptor glycoprotein (GP) IIb/IIIa" type="Drug_Class"><Normalization><mmtx cui="C0032188" phraseText="Concomitant treatment with other inhibitors of platelet receptor glycoprotein (GP) IIb/IIIa" preferredWord="Platelet Inhibitors" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><drugInteraction id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.35.ddi.1"><interaction trigger="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.35.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.35.e.2"/></relation><relation type="hasObject"><labelDrug text="Integrilin"/><normalization><mmtx><preferredWord>Integrilin</preferredWord><phraseText>&gt;Treatment with INTEGRILIN</phraseText><cuiCode>C0950902</cuiCode><semType>phsu</semType><semType>aapp</semType></mmtx></normalization></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.35.e.2"/></sentence><sentence biomedicalEntities="1" id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.36" lineNumber="59" text="In patients treated with heparin, bleeding can be minimized by close monitoring of the aPTT and ACT see Dosage and Administration (2)." type="irregular"><entity charOffset="34:42" id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.36.e.1" text="bleeding" type="Specific_Interaction"/><entity charOffset="25:32" id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.36.e.2" text="heparin" type="Drug"><Normalization><mmtx cui="C0019134" phraseText="treated with heparin," preferredWord="Heparin" semType="bacs, phsu, carb"/><mmtx cui="C0770546" phraseText="treated with heparin," preferredWord="heparin, porcine" semType="bacs, phsu, carb"/><RxNorm RxCui="5224"/></Normalization></entity><entity charOffset="69:79" id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.36.e.4" text="monitoring" type="Caution_Interaction"/><drugInteraction id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.36.ddi.1"><interaction trigger="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.36.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.36.e.2"/></relation><relation type="hasObject"><labelDrug text="Integrilin"/><normalization><mmtx><preferredWord>Integrilin</preferredWord><phraseText>&gt;Treatment with INTEGRILIN</phraseText><cuiCode>C0950902</cuiCode><semType>phsu</semType><semType>aapp</semType></mmtx></normalization></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.36.ddi.2"><interaction trigger="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.36.e.4"><relations><relation type="hasPrecipitant"><entity id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.36.e.2"/></relation><relation type="hasObject"><labelDrug text="Integrilin"/><normalization><mmtx><preferredWord>Integrilin</preferredWord><phraseText>&gt;Treatment with INTEGRILIN</phraseText><cuiCode>C0950902</cuiCode><semType>phsu</semType><semType>aapp</semType></mmtx></normalization></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.36.e.2"/></sentence><sentence id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.43" text="In any case, both heparin and INTEGRILIN should be discontinued and sheath hemostasis should be achieved at least 2 to 4 hours before hospital discharge. " type="negative"><entity charOffset="18:25" id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.43.e.0" text="heparin" type="Biomedical_Entity"><Normalization><mmtx cui="C0770546" phraseText="both heparin" preferredWord="heparin, porcine" semType="bacs, phsu, carb"/><RxNorm RxCui="5224"/></Normalization></entity><entity charOffset="30:40" id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.43.e.1" text="integrilin" type="Biomedical_Entity"><Normalization><mmtx cui="C0950902" phraseText="INTEGRILIN" preferredWord="Integrilin" semType="phsu, aapp"/><RxNorm RxCui="288688"/></Normalization></entity><pair ddi="false" e1="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.43.e.0" e2="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.43.e.1"/></sentence><sentence biomedicalEntities="2" id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.44" lineNumber="61" text="If bleeding at access site cannot be controlled with pressure, infusion of INTEGRILIN and heparin should be discontinued immediately." type="regular"><entity charOffset="3:11" id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.44.e.1" text="bleeding" type="Specific_Interaction"/><entity charOffset="63:74|90:97" id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.44.e.2" text="infusion of heparin" type="Drug"><Normalization><mmtx cui="C0950902" phraseText="infusion of INTEGRILIN" preferredWord="Integrilin" semType="phsu, aapp"/><mmtx cui="C0019134" phraseText="heparin" preferredWord="Heparin" semType="bacs, phsu, carb"/><mmtx cui="C0770546" phraseText="heparin" preferredWord="heparin, porcine" semType="bacs, phsu, carb"/><RxNorm RxCui="126307"/></Normalization></entity><entity charOffset="63:85" id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.44.e.3" text="infusion of INTEGRILIN" type="Drug"><Normalization><mmtx cui="C0950902" phraseText="infusion of INTEGRILIN" preferredWord="Integrilin" semType="phsu, aapp"/><RxNorm RxCui="126307"/></Normalization></entity><drugInteraction id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.44.ddi.1"><interaction trigger="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.44.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.44.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.44.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.44.e.2" e2="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.44.e.3" trigger="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.44.e.1" type="Specific_Interaction"/></sentence><sentence id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.46" text="There have been reports of acute, profound thrombocytopenia (immune-mediated and non-immune mediated) with INTEGRILIN. " type="negative"><entity charOffset="68:76" id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.46.e.0" text="mediated" type="Biomedical_Entity"><Normalization><mmtx cui="C0127400" phraseText="(immune-mediated" preferredWord="Mediator brand of benfluorex hydrochloride" semType="phsu, orch"/><RxNorm RxCui="985488"/></Normalization></entity><entity charOffset="92:100" id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.46.e.1" text="mediated" type="Biomedical_Entity"><Normalization><mmtx cui="C0127400" phraseText="non-immune mediated" preferredWord="Mediator brand of benfluorex hydrochloride" semType="phsu, orch"/><RxNorm RxCui="985488"/></Normalization></entity><entity charOffset="107:117" id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.46.e.2" text="integrilin" type="Biomedical_Entity"><Normalization><mmtx cui="C0950902" phraseText="with INTEGRILIN." preferredWord="Integrilin" semType="phsu, aapp"/><RxNorm RxCui="288688"/></Normalization></entity><pair ddi="false" e1="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.46.e.0" e2="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.46.e.2"/><pair ddi="false" e1="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.46.e.1" e2="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.46.e.2"/></sentence><sentence biomedicalEntities="4" id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.47" lineNumber="65" text="In the event of acute profound thrombocytopenia or a confirmed platelet decrease to 100,000/mm3, discontinue INTEGRILIN and heparin (unfractionated or low-molecular weight). " type="regular"><entity charOffset="16:47" id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.47.e.1" text="acute profound thrombocytopenia" type="Specific_Interaction"/><entity charOffset="109:119" id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.47.e.2" text="INTEGRILIN" type="Drug"><Normalization><mmtx cui="C0950902" phraseText="INTEGRILIN" preferredWord="Integrilin" semType="phsu, aapp"/><RxNorm RxCui="288688"/></Normalization></entity><entity charOffset="124:131" id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.47.e.3" text="heparin" type="Drug"><Normalization><mmtx cui="C0019134" phraseText="heparin" preferredWord="Heparin" semType="bacs, phsu, carb"/><mmtx cui="C0770546" phraseText="heparin" preferredWord="heparin, porcine" semType="bacs, phsu, carb"/><RxNorm RxCui="5224"/></Normalization></entity><entity charOffset="133:147" id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.47.e.5" text="unfractionated" type="Drug"><Normalization><RxNorm RxCui="1036221"/></Normalization></entity><entity charOffset="151:171" id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.47.e.7" text="low-molecular weight" type="Drug"><Normalization><RxNorm RxCui="6463"/></Normalization></entity><entity charOffset="63:80" id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.47.e.9" text="platelet decrease" type="Specific_Interaction"/><drugClassMembership drug="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.47.e.5" drugClass="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.47.e.3"/><drugClassMembership drug="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.47.e.7" drugClass="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.47.e.3"/><drugInteraction id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.47.ddi.1"><interaction trigger="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.47.e.1"><relations><relation type="hasObject"><entity id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.47.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.47.e.3"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.47.ddi.2"><interaction trigger="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.47.e.9"><relations><relation type="hasObject"><entity id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.47.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.47.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.47.e.2" e2="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.47.e.3" trigger="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.47.e.1" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="0" id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.48" lineNumber="65" text="Monitor serial platelet counts, assess the presence of drug-dependent antibodies, and treat as appropriate see Adverse Reactions (6.1)." type="irregular"><entity charOffset="0:7" id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.48.e.1" text="Monitor" type="Caution_Interaction"/><drugInteraction id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.48.ddi.1"><interaction trigger="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.48.e.1"><relations><relation type="hasObject"><ellipsisSentence id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.47" text="In the event of acute profound thrombocytopenia or a confirmed platelet decrease to 100,000/mm3, discontinue INTEGRILIN and heparin (unfractionated or low-molecular weight). "><entity id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.47.e.2"/></ellipsisSentence></relation><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.47" text="In the event of acute profound thrombocytopenia or a confirmed platelet decrease to 100,000/mm3, discontinue INTEGRILIN and heparin (unfractionated or low-molecular weight). "><entity id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.47.e.3"/></ellipsisSentence></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="5" id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.52" lineNumber="73" text="&lt;item&gt;Coadministration of antiplatelet agents, thrombolytics, heparin, aspirin, and chronic NSAID use increases the risk of bleeding. " type="irregular"><entity charOffset="124:132" id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.52.e.1" text="bleeding" type="Specific_Interaction"/><entity charOffset="71:78" id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.52.e.2" text="aspirin" type="Drug"><Normalization><mmtx cui="C0004057" phraseText="aspirin," preferredWord="Aspirin" semType="phsu, orch"/><RxNorm RxCui="1191"/></Normalization></entity><entity charOffset="26:45" id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.52.e.3" text="antiplatelet agents" type="Drug_Class"><Normalization><mmtx cui="C0085826" phraseText="&gt;Coadministration of antiplatelet agents," preferredWord="Antiplatelet Agents" semType="phsu"/><RxNorm RxCui="42539"/></Normalization></entity><entity charOffset="62:69" id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.52.e.4" text="heparin" type="Drug"><Normalization><mmtx cui="C0019134" phraseText="heparin," preferredWord="Heparin" semType="bacs, phsu, carb"/><mmtx cui="C0770546" phraseText="heparin," preferredWord="heparin, porcine" semType="bacs, phsu, carb"/><RxNorm RxCui="5224"/></Normalization></entity><entity charOffset="47:60" id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.52.e.5" text="thrombolytics" type="Drug_Class"><Normalization><mmtx cui="C0016018" phraseText="thrombolytics," preferredWord="Fibrinolytic Agents" semType="phsu"/><RxNorm RxCui="4390"/></Normalization></entity><entity charOffset="92:97" id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.52.e.6" text="NSAID" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="chronic NSAID use" preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="889"/></Normalization></entity><drugInteraction id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.52.ddi.1"><interaction trigger="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.52.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.52.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.52.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.52.e.4"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.52.e.5"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.52.e.6"/></relation><relation type="hasObject"><labelDrug text="Integrilin"/><normalization><mmtx><preferredWord>Integrilin</preferredWord><phraseText>&gt;Treatment with INTEGRILIN</phraseText><cuiCode>C0950902</cuiCode><semType>phsu</semType><semType>aapp</semType></mmtx></normalization></relation></relations></interaction></drugInteraction><pair ddi="false" e1="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.52.e.3" e2="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.52.e.2"/><pair ddi="false" e1="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.52.e.4" e2="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.52.e.2"/><pair ddi="false" e1="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.52.e.5" e2="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.52.e.2"/><pair ddi="false" e1="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.52.e.2" e2="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.52.e.6"/><pair ddi="false" e1="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.52.e.3" e2="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.52.e.4"/><pair ddi="false" e1="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.52.e.3" e2="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.52.e.5"/><pair ddi="false" e1="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.52.e.3" e2="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.52.e.6"/><pair ddi="false" e1="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.52.e.5" e2="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.52.e.4"/><pair ddi="false" e1="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.52.e.4" e2="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.52.e.6"/><pair ddi="false" e1="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.52.e.5" e2="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.52.e.6"/><pair ddi="true" e1="labelDrug" e2="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.52.e.2"/><pair ddi="true" e1="labelDrug" e2="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.52.e.3"/><pair ddi="true" e1="labelDrug" e2="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.52.e.4"/><pair ddi="true" e1="labelDrug" e2="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.52.e.5"/><pair ddi="true" e1="labelDrug" e2="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.52.e.6"/></sentence><sentence biomedicalEntities="1" id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.53" lineNumber="73" text="Avoid concomitant use with other glycoprotein (GP) IIb/IIIa inhibitors. " type="irregular"><entity charOffset="0:5" id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.53.e.1" text="Avoid" type="Caution_Interaction"/><entity charOffset="33:70" id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.53.e.2" text="glycoprotein (GP) IIb/IIIa inhibitors" type="Drug_Class"><Normalization><RxNorm RxCui="4954"/></Normalization></entity><drugInteraction id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.53.ddi.1"><interaction trigger="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.53.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.53.e.2"/></relation><relation type="hasObject"><labelDrug text="Integrilin"/><normalization><mmtx><preferredWord>Integrilin</preferredWord><phraseText>&gt;Treatment with INTEGRILIN</phraseText><cuiCode>C0950902</cuiCode><semType>phsu</semType><semType>aapp</semType></mmtx></normalization></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.53.e.2"/></sentence><sentence id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.55" text="7.1 Use of Thrombolytics, Anticoagulants, and Other Antiplatelet Agents" type="negative"><entity charOffset="52:71" id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.55.e.0" text="antiplatelet agents" type="Biomedical_Entity"><Normalization><mmtx cui="C0085826" phraseText="Other Antiplatelet Agents" preferredWord="Antiplatelet Agents" semType="phsu"/><RxNorm RxCui="42539"/></Normalization></entity><entity charOffset="26:40" id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.55.e.1" text="anticoagulants" type="Biomedical_Entity"><Normalization><mmtx cui="C0003280" phraseText="Anticoagulants," preferredWord="Anticoagulants" semType="phsu"/><RxNorm RxCui="923"/></Normalization></entity><entity charOffset="11:24" id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.55.e.2" text="thrombolytics" type="Biomedical_Entity"><Normalization><mmtx cui="C0016018" phraseText="7.1 Use of Thrombolytics," preferredWord="Fibrinolytic Agents" semType="phsu"/><RxNorm RxCui="4390"/></Normalization></entity><pair ddi="false" e1="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.55.e.1" e2="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.55.e.0"/><pair ddi="false" e1="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.55.e.2" e2="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.55.e.0"/><pair ddi="false" e1="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.55.e.2" e2="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.55.e.1"/></sentence><sentence biomedicalEntities="5" id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.56" lineNumber="80" text="Coadministration of antiplatelet agents, thrombolytics, heparin, aspirin, and chronic NSAID use increases the risk of bleeding. " type="irregular"><entity charOffset="118:126" id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.56.e.1" text="bleeding" type="Specific_Interaction"/><entity charOffset="65:72" id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.56.e.2" text="aspirin" type="Drug"><Normalization><mmtx cui="C0004057" phraseText="aspirin," preferredWord="Aspirin" semType="phsu, orch"/><RxNorm RxCui="1191"/></Normalization></entity><entity charOffset="86:91" id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.56.e.3" text="NSAID" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="chronic NSAID use" preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="889"/></Normalization></entity><entity charOffset="56:63" id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.56.e.4" text="heparin" type="Drug"><Normalization><mmtx cui="C0019134" phraseText="heparin," preferredWord="Heparin" semType="bacs, phsu, carb"/><mmtx cui="C0770546" phraseText="heparin," preferredWord="heparin, porcine" semType="bacs, phsu, carb"/><RxNorm RxCui="5224"/></Normalization></entity><entity charOffset="20:39" id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.56.e.5" text="antiplatelet agents" type="Drug_Class"><Normalization><mmtx cui="C0085826" phraseText="Coadministration of antiplatelet agents," preferredWord="Antiplatelet Agents" semType="phsu"/><RxNorm RxCui="42539"/></Normalization></entity><entity charOffset="41:54" id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.56.e.6" text="thrombolytics" type="Drug_Class"><Normalization><mmtx cui="C0016018" phraseText="thrombolytics," preferredWord="Fibrinolytic Agents" semType="phsu"/><RxNorm RxCui="4390"/></Normalization></entity><drugInteraction id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.56.ddi.1"><interaction trigger="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.56.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.56.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.56.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.56.e.5"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.56.e.4"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.56.e.6"/></relation><relation type="hasObject"><labelDrug text="Integrilin"/><normalization><mmtx><preferredWord>Integrilin</preferredWord><phraseText>&gt;Treatment with INTEGRILIN</phraseText><cuiCode>C0950902</cuiCode><semType>phsu</semType><semType>aapp</semType></mmtx></normalization></relation></relations></interaction></drugInteraction><pair ddi="false" e1="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.56.e.2" e2="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.56.e.3"/><pair ddi="false" e1="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.56.e.5" e2="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.56.e.2"/><pair ddi="false" e1="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.56.e.4" e2="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.56.e.2"/><pair ddi="false" e1="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.56.e.6" e2="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.56.e.2"/><pair ddi="false" e1="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.56.e.5" e2="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.56.e.3"/><pair ddi="false" e1="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.56.e.4" e2="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.56.e.3"/><pair ddi="false" e1="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.56.e.6" e2="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.56.e.3"/><pair ddi="false" e1="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.56.e.5" e2="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.56.e.4"/><pair ddi="false" e1="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.56.e.5" e2="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.56.e.6"/><pair ddi="false" e1="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.56.e.6" e2="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.56.e.4"/><pair ddi="true" e1="labelDrug" e2="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.56.e.2"/><pair ddi="true" e1="labelDrug" e2="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.56.e.3"/><pair ddi="true" e1="labelDrug" e2="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.56.e.5"/><pair ddi="true" e1="labelDrug" e2="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.56.e.4"/><pair ddi="true" e1="labelDrug" e2="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.56.e.6"/></sentence><sentence biomedicalEntities="1" id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.57" lineNumber="80" text="Concomitant treatment with other inhibitors of platelet receptor GP IIb/IIIa should be avoided." type="irregular"><entity charOffset="87:94" id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.57.e.1" text="avoided" type="Caution_Interaction"/><entity charOffset="33:76" id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.57.e.2" text="inhibitors of platelet receptor GP IIb/IIIa" type="Drug_Class"><Normalization><mmtx cui="C0032188" phraseText="Concomitant treatment with other inhibitors of platelet receptor GP IIb/IIIa" preferredWord="Platelet Inhibitors" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><drugInteraction id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.57.ddi.1"><interaction trigger="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.57.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.57.e.2"/></relation><relation type="hasObject"><labelDrug text="Integrilin"/><normalization><mmtx><preferredWord>Integrilin</preferredWord><phraseText>&gt;Treatment with INTEGRILIN</phraseText><cuiCode>C0950902</cuiCode><semType>phsu</semType><semType>aapp</semType></mmtx></normalization></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.5ad82e30-50d8-450c-8a2a-b4b507ed1ce2.s.57.e.2"/></sentence><positiveExamples number="19"/><negativeExamples number="33"/></document>